CURRENT DIVERSIFICATION IN THE SELECTION OF MOLECULE(s) FOR THE TREATMENT OF HYPERTENSION

The study was carried out on the current diversification of antihypertensive drugs prescribed for treatment hypertensive patients irrespective age and sex in Government Hospitals Khulna city, Bangladesh. covered only indoor patients. frequency hypertension found maximum with above 40 years age. showed that prevalence more common females compared to males. Among therapeutic classes, Calcium channel blockers (CCB) were used most frequently (27%). Diuretics (25%) Beta-blocker (24%) fell 2nd 3rd position respectively. ACE inhibitors (18%) also frequently, but angiotensin-II antagonist, alpha-blocker centrally acting limited cases. Both combination therapy (57%) monotherapy (43%) management hypertension. combinations, diuretics cases (20%). There no two or molecules under same class. In case mono-drug metoprolol which followed by amlodipine (20%) nifedipine (18%). When individual drug their use either as single taken into account, it furosemide (21%) used. Amlodipine (16%), atenolol (13%) furosemide.